Search

Orthopedic device-related infection (ODRI) poses a significant threat to patients with titanium-based implants. The challenge lies in developing antibacterial surfaces that preserve the bulk mechanical properties of titanium implants while exhibiting characteristics similar to bone tissue. In response, we present a two-step approach: silver nanoparticle (AgNP) coating followed by selective laser-assisted surface alloying on commonly used titanium alumina vanadium (TiAl6V4) implant surfaces. This process imparts antibacterial properties without compromising the bulk mechanical characteristics of the titanium alloy. Systematic optimization of laser beam power (8-40 W) resulted in an optimized surface (32 W) with uniform TiAg alloy formation. This surface displayed a distinctive hierarchical mesoporous textured surface, featuring cauliflower-like nanostructures measuring between 5-10 nm uniformly covering spatial line periods of 25 µm while demonstrating homogenous elemental distribution of silver throughout the laser processed surface. The optimized laser processed surface exhibited prolonged superhydrophilicity (40 days) and antibacterial efficacy (12 days) against Staphylococcus aureus and Escherichia coli. Additionally, there was a significant twofold increase in bone mineralization compared to the pristine Ti6Al4V surface (p < 0.05). Rockwell hardness tests confirmed minimal (<1%) change in bulk mechanical properties compared to the pristine surface. This innovative laser-assisted approach, with its precisely tailored surface morphology, holds promise for providing enduring antibacterial and osteointegration properties, rendering it an optimal choice for modifying load-bearing implant devices without altering material bulk characteristics. [ABSTRACT FROM AUTHOR]

Copper oxide nanostructures are widely used for various applications due to their unique optical and electrical properties. In this work, we demonstrate an atmospheric laser-induced oxidation technique for the fabrication of highly electrochemically active copper oxide hierarchical micro/nano structures on copper surfaces to achieve highly sensitive non-enzymatic glucose sensing performance. The effect of laser processing power on the composition, crystallinity, microstructure, wettability, and color of the laser-induced oxide on copper (LIO-Cu) surface was systematically studied using scanning electron microscopy (SEM), grazing incidence X-ray diffraction (GI-XRD), Raman spectroscopy, energy dispersive X-ray spectroscopy (EDX), EDX-mapping, water contact angle measurements, and optical microscopy. Results of these investigations showed a remarkable increase in copper oxide composition by increasing the laser processing power. The pore size distribution and surface area of the pristine and LIO-Cu sample estimated by N2 adsorption–desorption data showed a developed mesoporous LIO-Cu structure. The size of the generated nano-oxides, crystallinity, and electroactivity of the LIO-Cu were observed to be adjustable by the laser processing power. The electrocatalytic activity of LIO-Cu surfaces was studied by means of cyclic voltammetry (CV) within a potential window of −0.8 to +0.8 V and chronoamperometry in an applied optimized potential of +0.6 V, in 0.1 M NaOH solution and phosphate buffer solution (PBS), respectively. LIO-Cu surfaces with optimized laser processing powers exhibited a sensitivity of 6950 μA mM−1 cm−2 within a wide linear range from 0.01 to 5 mM, with exceptional specificity and response time (<3 seconds). The sensors also showed excellent response stability over a course of 50 days that was originated from the binder-free robust electroactive film fabricated directly onto the copper surface. The demonstrated one-step LIO processing onto commercial metal films, can potentially be applied for tuneable and scalable roll-to-roll fabrication of a wide range of high surface area metal oxide micro/nano structures for non-enzymatic biosensing and electrochemical applications. [ABSTRACT FROM AUTHOR]

Although serum and fecal biomarkers ( e.g. , lactoferrin, and calprotectin) have been used in management and distinction between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), none are proven to be a differential diagnostic tool between Crohn's disease (CD) and ulcerative colitis (UC). The main challenge with laboratory-based biomarkers in the stool test is the inability to indicate the location of the disease/inflammation in the gastrointestinal (GI) tract due to the homogenous nature of the collected fecal sample. For the first time, we have designed and developed a battery-free smart capsule that will allow targeted sampling of inflammatory biomarkers inside the gut lumen of the small intestine. The capsule is designed to provide a simple and non-invasive complementary tool to fecal biomarker analysis to differentiate the type of IBD by pinpointing the site of inflammatory biomarkers secretion ( e.g. , small or large bowel) throughout the GI tract. The capsule takes advantage of the rapid change from an acidic environment in the stomach to higher pH levels in the small intestine to dissolve a pH-sensitive polymeric coating as a means to activate the sampling process of the capsule within the small intestine. A swelling polyacrylamide hydrogel is placed inside the capsule as a milieu to collect the sampled GI fluid while also providing the required mechanical actuation to close the capsule once the sampling is completed. The hydrogel component along with the collected GI fluid can be easily obtained from the capsule through the screw-cap design for further extraction and analysis. As a proof of concept, the capsule's performance in sampling and extraction of bovine serum albumin (BSA) and calprotectin - a key biomarker of inflammation - was assessed within the physiologically relevant ranges. The ratio of extracted biomarkers relative to that in the initial sampling environment remained constant (∼3%) and independent of the sampling matrix in both in vitro and ex vivo studies. It is believed that the demonstrated technology will provide immediate impact in more effective IBD type differential diagnostic and treatment strategies by providing a non-invasive assessment of inflammation biomarkers profile throughout the digestive tract.